Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients
Haeyoung Kim, Doo Ho Choi, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Jin Seok Ahn, Young-Hyuck Im
Radiat Oncol J. 2013;31(4):222-227.   Published online 2013 Dec 31     DOI: https://doi.org/10.3857/roj.2013.31.4.222
Citations to this article as recorded by Crossref logo
Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer
Lou Hochheiser, John Hornberger, Michelle Turner, Gary H Lyman
Journal of Comparative Effectiveness Research.2019; 8(5): 289.     CrossRef
Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer—A Single Institution Experience
Bianca Rogoz, Agathe Houzé de l'Aulnoit, Alain Duhamel, Denis Houzé de l'Aulnoit
Clinical Breast Cancer.2018; 18(3): 246.     CrossRef
Metastasis-free interval in breast cancer patients: Thirty-year trends and time dependency of prognostic factors. A retrospective analysis based on a single institution experience
A. Houzé de l’Aulnoit, B. Rogoz, C. Pinçon, D. Houzé de l’Aulnoit
The Breast.2018; 37: 80.     CrossRef
Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer
Shelvin K. Vadi, Bhagwant R. Mittal, Ashwani Sood, Gurpreet Singh, Amanjit Bal, Ashwin S. Parihar, Anish Bhattacharya, Rajender K. Basher, Rakesh Kapoor
Nuclear Medicine Communications.2018; : 1.     CrossRef
Lifetime cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for early stage breast cancer
Rakesh Patel, Olga Ivanov, Jeff Voigt
Cost Effectiveness and Resource Allocation.2017;[Epub]     CrossRef
Patterns of recurrence and treatment in male breast cancer: A clue to prognosis?
Miguel Henriques Abreu, Pedro Henriques Abreu, Noémia Afonso, Deolinda Pereira, Rui Henrique, Carlos Lopes
International Journal of Cancer.2016; 139(8): 1715.     CrossRef
Optimal surveillance for postoperative metastasis in breast cancer patients
Masujiro Makita, Takehiko Sakai, Akiko Ogiya, Dai Kitagawa, Hidetomo Morizono, Yumi Miyagi, Kotaro Iijima, Takuji Iwase
Breast Cancer.2016; 23(2): 286.     CrossRef
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study
Stefania Gori, Alessandro Inno, Valentina Rossi, Monica Turazza, Elena Fiorio, Alessandra Fabi, Giancarlo Bisagni, Jennifer Foglietta, Daniele Santini, Ida Pavese, Arianna Pellegrino, Alberto Zambelli, Patrizia Vici, Vita Leonardi, Sandro Barni, Silvana S
PLOS ONE.2016; 11(5): e0156221.     CrossRef
Features of aggressive breast cancer
Grazia Arpino, Monica Milano, Sabino De Placido
The Breast.2015; 24(5): 594.     CrossRef
Analysis of Indoleamine 2-3 Dioxygenase (IDO) and EGFR Co-expression in Breast Cancer Tissue by Immunohistochemistry
Wei-Wei Bi, Wei-Hua Zhang, Gui-Hua Yin, Hong Luo, Shou-Qin Wang, Hongran Wang, Chao Li, Wei-Qun Yan, De-Zhi Nie
Asian Pacific Journal of Cancer Prevention.2014; 15(14): 5535.     CrossRef